Mary Ann Liebert, Inc. is a leading company in the Scientific, Technical, and Medical knowledge and information industry. We are known for authoritative international publications in cutting-edge basic and translational biomedical research, with expanding scope in engineering, business, environment, and legal publications. These publications play an active and important role in advancing critical research and facilitating collaboration throughout the world in academia, industry, and government, and are also highly respected resources for legislators, policy makers, and educators.
Mary Ann Liebert, Inc. invests substantially in technology-enabled content delivery systems and solutions to maximize the promise of global scientific exchange, and embraces new publishing models. The information industry is evolving rapidly and new technologies provide new challenges and opportunities. We have seen enormous uptake in our online content usage around the world, and we remain committed to driving innovation in delivering relevant, must-have information in multiple media formats.
Our flagship publication, Genetic Engineering & Biotechnology News (GEN) was the first trade magazine in what was then a fledgling industry. Today GEN is the most widely read publication in its field worldwide, and our company is acknowledged as the leading publisher in biotechnology.
We invite you to browse our publications, explore the contents of our established journals, and learn about the newest titles in our collection. As always, we welcome your feedback and input. We are committed to continuing to do our very best to meet the needs of the members of academia, government, and industry—in the public and private sectors—around the world.
Mary Ann Liebert